InvestorsHub Logo
icon url

flipper44

12/31/21 10:14 AM

#430963 RE: Long and gone #430962

I haven't seen the article, but if accurate, it would mean per patient (if all six doses were administered), not per dose. Please try to link the article.
icon url

vator

12/31/21 10:15 AM

#430964 RE: Long and gone #430962

$250K per patient. But a couple of years ago they had not decided what to charge when starting production on an approved product. People wanting the specials program are raising around $250K.
icon url

Doc logic

12/31/21 11:12 AM

#430994 RE: Long and gone #430962

Long and gone,

The combo trial requires only 3 doses over a 1 month period possibly with the idea in mind that the combo with ICLC and especially pembro might create a more robust or longer lasting immune response. There were only 5 doses required with up to 10 made and administered for participation in the Phase 3 trial. Most immune responses will happen before or around 8 weeks after first treatment which is basically the 5 dose schedule. Any 6th dose would be like a booster. Best wishes.
icon url

sentiment_stocks

12/31/21 11:23 AM

#430997 RE: Long and gone #430962

I really do think they intend to charge a fee per dose, so I don’t know how accurate the $250k for the entire dose set is.